Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Anemia: full-pipeline trial registry
14 of 74 indexed Anemia trials are currently recruiting.
Corpus placement: #183 of 28,707 conditions by registered trial count.
74 US clinical trials · 14 currently recruiting · #183 of 28,707 conditions by registered trial count
Anemia: 74 US clinical trials tracked, 14 recruiting.
Anemia is the subject of 74 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 26 are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most active sponsor is Akebia Therapeutics, running 5 of these trials.
Enrollment posture brief
Registry condition anemia
OPEN 14 | RECR 19% | LATE 26 | EARLY 25 | RANK #183 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Colonoscopy (19% recruiting · 21 trials)
Anemia lists 14 open slots (19% of 74 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Anemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Anemia is recruiting below its size-band peers.
14 of 74 indexed trials (18.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Anemia trials is spread across many organizations.
Akebia Therapeutics accounts for 5 of 74 trials (6.8%). 54 distinct sponsors appear on at least one study for this condition label.
-
Typical Anemia enrolment sits around 161 participants.
Median target enrolment is 161 among the 73 trials that report a genuine target (sentinel values excluded). 27 of those (37%) plan for fewer than 100 participants.
-
Anemia research is mostly interventional.
69 interventional and 5 observational studies make up this index (93.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
74 total, page 1 of 2
Diamond Blackfan Anemia Registry (DBAR)
Northwell Health
NCT00106015
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
The University of Texas Health Science Center, Houston
NCT05750654
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
The University of Texas Health Science Center, Houston
NCT05735314
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Takeda
NCT07422480
Choline and Iron Deficiency
University of Minnesota
NCT06527391
Kids With Iron Deficiency and Scoliosis
Columbia University
NCT06042699
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Disc Medicine
NCT05320198
129Xe MRI Cardiopulmonary
Bastiaan Driehuys
NCT06038630
Iron Deficiency Anemia (IDA) and the Brain
Children's Hospital Los Angeles
NCT05929729
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
H. Lee Moffitt Cancer Center and Research Institute
NCT05732961
Luspatercept for Clonal Cytopenias of Uncertain Significance
Weill Medical College of Cornell University
NCT06788691
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
NCT07025512
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Fox Chase Cancer Center
NCT05800600
Study of DISC-0974-201 in Participants With IBD and Anemia
Disc Medicine
NCT07368972
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
Brigham and Women's Hospital
NCT01632761
INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
Cerus Corporation
NCT03037164
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
NCT02048813
RBC Irradiation, Anemia and Gut Injury
Emory University
NCT02741648
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
Celgene
NCT04717414
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
National Cancer Institute (NCI)
NCT00843882
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
Incyte Corporation
NCT04455841
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
Cure HHT
NCT03850964
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
Nutraceuticals Research Institute
NCT07199244
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Akebia Therapeutics
NCT02892149
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
AstraZeneca
NCT02174627
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
American Regent
NCT00548860
Transfusion of Prematures Trial
NICHD Neonatal Research Network
NCT01702805
Helen Keller International's Enhanced-Homestead Food Production Program in Burkina Faso
International Food Policy Research Institute
NCT01825226
Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease
Akebia Therapeutics
NCT02648347
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
University of Utah
NCT05634005
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
Affymax
NCT00597753
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
American Regent
NCT00740246
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Mayo Clinic
NCT00661999
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Masimo Corporation
NCT02930850
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Sandoz
NCT01693029
PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00440466
Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors
Medical College of Wisconsin
NCT00772083
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Hoffmann-La Roche
NCT00081471
Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
Akebia Therapeutics
NCT04313153
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
Eastern Cooperative Oncology Group
NCT00060398
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
Memorial Sloan Kettering Cancer Center
NCT00003341
Frozen Red Blood Cell Transfusions in Trauma Patients
Oregon Health and Science University
NCT01038557
Prevention of Iron Deficiency in Breastfed Infants
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT01444261
20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Akebia Therapeutics
NCT01906489
Iron Depletion and Replacement in Blood Donors
Memorial Blood Centers, Minnesota
NCT01752413
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
Takeda
NCT01478971
A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women
AMAG Pharmaceuticals
NCT00360425
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
USRC Kidney Research
NCT05951192
Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants
The University of Texas Health Science Center, Houston
NCT01224236
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
Masimo Corporation
NCT03610269
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 19 |
| Phase 3 | 20 |
| Phase 4 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Anemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Anemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Anemia page
74 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Anemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Akebia Therapeutics sponsors the most Anemia trials on record, review their full trial history before evaluating a specific study. See Akebia Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anemia condition card totals 74 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.